{
    "organizations": [],
    "uuid": "ca744ed34a4bcf4a5f596396073a690a8c6b5967",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-clovis-oncology-q4-adjusted-loss-p/brief-clovis-oncology-q4-adjusted-loss-per-share-1-27-idUSASB0C7IC",
    "ord_in_thread": 0,
    "title": "BRIEF-Clovis Oncology Q4 Adjusted Loss Per Share $1.27",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Clovis Oncology Inc:\n* CLOVIS ONCOLOGY ANNOUNCES 2017 OPERATING RESULTS * Q4 ADJUSTED LOSS PER SHARE $1.27 EXCLUDING ITEMS * Q4 LOSS PER SHARE $1.04 * QTRLY ‍​NET PRODUCT REVENUE $17 MILLION VERSUS $78,000 * Q4 REVENUE VIEW $20.1 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-27T05:42:00.000+02:00",
    "crawled": "2018-02-27T15:14:59.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "clovis",
        "oncology",
        "inc",
        "clovis",
        "oncology",
        "announces",
        "operating",
        "result",
        "q4",
        "adjusted",
        "loss",
        "per",
        "share",
        "excluding",
        "item",
        "q4",
        "loss",
        "per",
        "share",
        "qtrly",
        "product",
        "revenue",
        "million",
        "versus",
        "q4",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}